Sanofi, GSK COVID-19 vaccine found effective against Omicron
The vaccine targets the beta variant – first identified in South Africa – as well as the original Wuhan strain of the virus
Author
Smallpox drugmakers get new orders as monkeypox spreads
More than 3,000 confirmed cases of monkeypox have been reported from 40 countries where the disease is not endemic
Moderna to build new vaccine facility in Britain
Britain's health ministry said that the pandemic had shown mRNA technology as one of the fastest routes to develop new vaccines,…
AstraZeneca and Ionis eye US approval after positive trial data
Based on the results, the companies plan to file an application to market the therapy in the US later this year in patients with…
Pfizer to buy 8.1 per cent stake in Valneva
Pfizer will buy the stake in Valneva, which is also working on its COVID-19 vaccine, at a price of 9.49 euros per share, via a…
EU drugs watchdog begins review of Moderna’s variant COVID vaccine
The US-based Moderna's so-called bivalent vaccine targets two strains of the SARS-CoV-2 virus behind COVID, the original strain…
Omnicron less likely to cause long COVID: UK Study
Researchers at King's College London found the odds of developing long COVID after infection were 20 per cent to 50 per cent lower…
WHO in process of procuring monkeypox tests for Africa, recommends vaccine readiness
The World Health Organisation (WHO) is in the process of procuring thousands of monkeypox tests for Africa but is not recommending…
BioNTech to soon start mRNA vaccine factory construction in Rwanda
The German company's modular factory elements, to be assembled in Africa to so-called BioNTainers, would be delivered to the…
J&J gives notice to terminate Emergent manufacturing deal for COVID vaccine
The termination notice comes about a week after J&J had initially informed Emergent of its intent to end the pact based on the…